Theratechnologies organizacji Zalecenie średnie
Jaka jest wartość Zalecenie średnie organizacji Theratechnologies?
Wartość Zalecenie średnie organizacji Theratechnologies, Inc. to 2.60
Jaka jest definicja Zalecenie średnie?
Średnia rekomendacja to średnia ocen analityków dla akcji od 1,0 (silny zakup) do 5,0 (silny wzrost).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Zalecenie średnie firm w Health Care sektor na TSX w porównaniu do Theratechnologies
Czym się zajmuję organizacja Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Firmy z zalecenie średnie podobne do Theratechnologies
- Wartość Zalecenie średnie organizacji HD Supply Inc to 2.57
- Wartość Zalecenie średnie organizacji Jounce Therapeutics Inc to 2.57
- Wartość Zalecenie średnie organizacji U.S. Bancorp to 2.58
- Wartość Zalecenie średnie organizacji HF Sinclair to 2.58
- Wartość Zalecenie średnie organizacji Church & Dwight Co to 2.58
- Wartość Zalecenie średnie organizacji HP Inc to 2.59
- Wartość Zalecenie średnie organizacji Theratechnologies to 2.60
- Wartość Zalecenie średnie organizacji Galapagos NV to 2.61
- Wartość Zalecenie średnie organizacji Redfin Corp to 2.61
- Wartość Zalecenie średnie organizacji Texas Instruments to 2.61
- Wartość Zalecenie średnie organizacji Tenaris S.A to 2.62
- Wartość Zalecenie średnie organizacji DaVita Inc to 2.62
- Wartość Zalecenie średnie organizacji Laredo Petroleum to 2.62